Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species
Roseburia intestinalis is an anaerobic, Gram-positive, slightly curved rod-shaped flagellated bacterium that produces butyrate in the colon. R. intestinalis has been shown to prevent intestinal inflammation and maintain energy homeostasis by producing metabolites. Evidence shows that this bacterium...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/209ac82b7d0e4a4b8e2a77339a4a7a0d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:209ac82b7d0e4a4b8e2a77339a4a7a0d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:209ac82b7d0e4a4b8e2a77339a4a7a0d2021-11-30T10:16:00ZRoseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species2235-298810.3389/fcimb.2021.757718https://doaj.org/article/209ac82b7d0e4a4b8e2a77339a4a7a0d2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcimb.2021.757718/fullhttps://doaj.org/toc/2235-2988Roseburia intestinalis is an anaerobic, Gram-positive, slightly curved rod-shaped flagellated bacterium that produces butyrate in the colon. R. intestinalis has been shown to prevent intestinal inflammation and maintain energy homeostasis by producing metabolites. Evidence shows that this bacterium contributes to various diseases, such as inflammatory bowel disease, type 2 diabetes mellitus, antiphospholipid syndrome, and atherosclerosis. This review reveals the potential therapeutic role of R. intestinalis in human diseases. Patients with inflammatory bowel disease exhibit significant changes in R. intestinalis abundance, and they may benefit a lot from modulations targeting R. intestinalis. The data reviewed here demonstrate that R. intestinalis plays its role in regulating barrier homeostasis, immune cells, and cytokine release through its metabolite butyrate, flagellin and other. Recent advancements in the application of primary culture technology, culture omics, single-cell sequencing, and metabonomics technology have improved research on Roseburia and revealed the benefits of this bacterium in human health and disease treatment.Kai NieKai NieKejia MaKejia MaWeiwei LuoWeiwei LuoZhaohua ShenZhaohua ShenZhenyu YangZhenyu YangMengwei XiaoMengwei XiaoTing TongTing TongYuanyuan YangYuanyuan YangXiaoyan WangXiaoyan WangFrontiers Media S.A.articleRoseburiaRoseburia intestinalisprobioticinflammatory bowel disease (IBD)microbiomeMicrobiologyQR1-502ENFrontiers in Cellular and Infection Microbiology, Vol 11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Roseburia Roseburia intestinalis probiotic inflammatory bowel disease (IBD) microbiome Microbiology QR1-502 |
spellingShingle |
Roseburia Roseburia intestinalis probiotic inflammatory bowel disease (IBD) microbiome Microbiology QR1-502 Kai Nie Kai Nie Kejia Ma Kejia Ma Weiwei Luo Weiwei Luo Zhaohua Shen Zhaohua Shen Zhenyu Yang Zhenyu Yang Mengwei Xiao Mengwei Xiao Ting Tong Ting Tong Yuanyuan Yang Yuanyuan Yang Xiaoyan Wang Xiaoyan Wang Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species |
description |
Roseburia intestinalis is an anaerobic, Gram-positive, slightly curved rod-shaped flagellated bacterium that produces butyrate in the colon. R. intestinalis has been shown to prevent intestinal inflammation and maintain energy homeostasis by producing metabolites. Evidence shows that this bacterium contributes to various diseases, such as inflammatory bowel disease, type 2 diabetes mellitus, antiphospholipid syndrome, and atherosclerosis. This review reveals the potential therapeutic role of R. intestinalis in human diseases. Patients with inflammatory bowel disease exhibit significant changes in R. intestinalis abundance, and they may benefit a lot from modulations targeting R. intestinalis. The data reviewed here demonstrate that R. intestinalis plays its role in regulating barrier homeostasis, immune cells, and cytokine release through its metabolite butyrate, flagellin and other. Recent advancements in the application of primary culture technology, culture omics, single-cell sequencing, and metabonomics technology have improved research on Roseburia and revealed the benefits of this bacterium in human health and disease treatment. |
format |
article |
author |
Kai Nie Kai Nie Kejia Ma Kejia Ma Weiwei Luo Weiwei Luo Zhaohua Shen Zhaohua Shen Zhenyu Yang Zhenyu Yang Mengwei Xiao Mengwei Xiao Ting Tong Ting Tong Yuanyuan Yang Yuanyuan Yang Xiaoyan Wang Xiaoyan Wang |
author_facet |
Kai Nie Kai Nie Kejia Ma Kejia Ma Weiwei Luo Weiwei Luo Zhaohua Shen Zhaohua Shen Zhenyu Yang Zhenyu Yang Mengwei Xiao Mengwei Xiao Ting Tong Ting Tong Yuanyuan Yang Yuanyuan Yang Xiaoyan Wang Xiaoyan Wang |
author_sort |
Kai Nie |
title |
Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species |
title_short |
Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species |
title_full |
Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species |
title_fullStr |
Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species |
title_full_unstemmed |
Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species |
title_sort |
roseburia intestinalis: a beneficial gut organism from the discoveries in genus and species |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/209ac82b7d0e4a4b8e2a77339a4a7a0d |
work_keys_str_mv |
AT kainie roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies AT kainie roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies AT kejiama roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies AT kejiama roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies AT weiweiluo roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies AT weiweiluo roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies AT zhaohuashen roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies AT zhaohuashen roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies AT zhenyuyang roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies AT zhenyuyang roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies AT mengweixiao roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies AT mengweixiao roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies AT tingtong roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies AT tingtong roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies AT yuanyuanyang roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies AT yuanyuanyang roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies AT xiaoyanwang roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies AT xiaoyanwang roseburiaintestinalisabeneficialgutorganismfromthediscoveriesingenusandspecies |
_version_ |
1718406671285354496 |